Impact of COVID-19 pandemic on cancer care: A cross-sectional study of Egyptian patients' perspectives and concerns.

COVID-19 and healthcare accessibility Cancer care adjustments Egyptian cancer patients and survivors Healthcare provision Modification of cancer treatment Online survey Patients’ concerns, beliefs, and knowledge Patients’ perspectives Remote consultations

Journal

Journal of cancer policy
ISSN: 2213-5383
Titre abrégé: J Cancer Policy
Pays: England
ID NLM: 101639933

Informations de publication

Date de publication:
12 2022
Historique:
received: 12 07 2022
revised: 06 08 2022
accepted: 19 08 2022
pubmed: 26 8 2022
medline: 21 12 2022
entrez: 25 8 2022
Statut: ppublish

Résumé

Worldwide, COVID-19 greatly reduced healthcare accessibility and utilization by non-COVID patients including cancer. This study aimed to quantify and characterize cancer care adjustments experienced by cancer patients/survivors; and to explore their concerns, beliefs, and knowledge regarding COVID-19. A cross-sectional study was conducted using a questionnaire distributed through social media patients' groups (June-December 2020). Questionnaire included basic information, care adjustments (in "care provision" and in "treatment plan"), and patients' concerns, beliefs, and knowledge. Data description and analysis were done. Out of 300 participants, there were 68.0% on-treatment and 32.0% in follow-up stage. Care adjustments were reported by 29.7%; mostly in care provision (27.3%) rather than treatment plan (4.9%). Adjustments were less likely to occur when healthcare facility was in governorate other than that of residence (OR:0.53, 95%CI:0.30-0.96, P = 0.037) and more likely with long-standing diagnosis (≥12 months) compared with recent (<3 months) (adjusted-OR:4.13, 95%CI:1.19-14.34, P = 0.026). Lower proportion of on-treatment patients used remote consultation than patients in follow-up [4.4% versus 17.7%, P < 0.001]. Patients were concerned about fulfilling their care visits more than the probable COVID-19 infection (72.3%). It was uncommon to feel that the risk of COVID-19 infection is higher in care places than in the community (27.3%) or to feel safe with remote consultations (34.3%). However, patients increased their infection control practice (64.0%) and the majority were aware of their increased susceptibility to complications (86.0%). Somewhat, they were also concerned about the care quality (57.3%). Many had adequate access to COVID-19 information (69.0%) and their main sources were the Ministry of Health webpage and ordinary media (radio/TV). Cancer patients were primarily concerned about fulfilling their planned care and COVID-19 infection was less appreciated. Launching of a policy for enhancement of telemedicine experience through more patients' engagement-as essential stakeholders-may be required. To heighten pandemic resilience for cancer care in Egypt, more investment in establishing specialized end-to-end cancer care facilities that ensure continuity of care may be justified.

Sections du résumé

BACKGROUND
Worldwide, COVID-19 greatly reduced healthcare accessibility and utilization by non-COVID patients including cancer. This study aimed to quantify and characterize cancer care adjustments experienced by cancer patients/survivors; and to explore their concerns, beliefs, and knowledge regarding COVID-19.
METHODS
A cross-sectional study was conducted using a questionnaire distributed through social media patients' groups (June-December 2020). Questionnaire included basic information, care adjustments (in "care provision" and in "treatment plan"), and patients' concerns, beliefs, and knowledge. Data description and analysis were done.
RESULTS
Out of 300 participants, there were 68.0% on-treatment and 32.0% in follow-up stage. Care adjustments were reported by 29.7%; mostly in care provision (27.3%) rather than treatment plan (4.9%). Adjustments were less likely to occur when healthcare facility was in governorate other than that of residence (OR:0.53, 95%CI:0.30-0.96, P = 0.037) and more likely with long-standing diagnosis (≥12 months) compared with recent (<3 months) (adjusted-OR:4.13, 95%CI:1.19-14.34, P = 0.026). Lower proportion of on-treatment patients used remote consultation than patients in follow-up [4.4% versus 17.7%, P < 0.001]. Patients were concerned about fulfilling their care visits more than the probable COVID-19 infection (72.3%). It was uncommon to feel that the risk of COVID-19 infection is higher in care places than in the community (27.3%) or to feel safe with remote consultations (34.3%). However, patients increased their infection control practice (64.0%) and the majority were aware of their increased susceptibility to complications (86.0%). Somewhat, they were also concerned about the care quality (57.3%). Many had adequate access to COVID-19 information (69.0%) and their main sources were the Ministry of Health webpage and ordinary media (radio/TV).
CONCLUSION
Cancer patients were primarily concerned about fulfilling their planned care and COVID-19 infection was less appreciated.
POLICY SUMMARY
Launching of a policy for enhancement of telemedicine experience through more patients' engagement-as essential stakeholders-may be required. To heighten pandemic resilience for cancer care in Egypt, more investment in establishing specialized end-to-end cancer care facilities that ensure continuity of care may be justified.

Identifiants

pubmed: 36007875
pii: S2213-5383(22)00038-8
doi: 10.1016/j.jcpo.2022.100359
pmc: PMC9395284
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100359

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of interest None.

Références

J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Eur J Cancer. 2020 Nov;139:43-50
pubmed: 32971510
Lancet Oncol. 2021 Jul;22(7):970-976
pubmed: 34051879
Ann Oncol. 2020 Oct;31(10):1320-1335
pubmed: 32745693
Ann Intern Med. 2020 Jun 2;172(11):756-758
pubmed: 32219410
Eur J Cancer. 2020 Sep;136:132-139
pubmed: 32683273
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
PLoS One. 2021 Sep 17;16(9):e0257420
pubmed: 34534231
Ecancermedicalscience. 2021 Jul 07;15:1263
pubmed: 34567248

Auteurs

Aalaa M Abdou (AM)

El-Zaitoun Specialized Hospital, 15 Omar El Mokhtar St., El Amireya, Cairo, Egypt.

Sahar K Kandil (SK)

Department of Community, Environmental, and Occupational Medicine, Faculty of Medicine, Ain Shams University, 38th Ramses St., Abbassiya Square, Cairo, Egypt. Electronic address: saharkandil@med.asu.edu.eg.

Mohamed Yassin (M)

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, 38 Ramses St., Abbassiya Square, Cairo, Egypt.

Mohamed Atef (M)

Shefa Al Orman Oncology Hospital, l̥4th District, Tiba City, Luxor, Egypt.

Sali A El-Yamani (SA)

Dar El-Shefa Hospital, l̥25th Mohammed Al Fahmi St., Al Abbassiya, Cairo, Egypt.

Ahmed H Abdelaziz (AH)

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Ain Shams University, 38 Ramses St., Abbassiya Square, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH